Catheter Precision, Inc. Debt Securities, Available-for-sale, Amortized Cost
Catheter Precision, Inc. (VTAK) had Debt Securities, Available-for-sale, Amortized Cost of $5.00 million as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2021-03-17
- 2020-03-31: Debt Securities, Available-for-sale, Amortized Cost $5.00M.
- 2019-12-31: Debt Securities, Available-for-sale, Amortized Cost $15.97M.
- 2019-09-30: Debt Securities, Available-for-sale, Amortized Cost $25.93M.
- 2019-06-30: Debt Securities, Available-for-sale, Amortized Cost $36.55M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2020-03-31 | $5.00M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $15.97M 10-K · filed 2021-03-17 |
| 2019-09-30 | $25.93M 10-Q · filed 2019-11-29 |
| 2019-06-30 | $36.55M 10-Q · filed 2019-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |